Puretech Health Plc Stock Analysis

PureTech Stock Analysis Notes

The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health PLC had not issued any dividends in recent years. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. To find out more about PureTech Health PLC contact the company at 617 482 2333 or learn more at https://www.puretechhealth.com.

PureTech Health PLC Investment Alerts

PureTech Health PLC Upcoming and Recent Events

PureTech Largest EPS Surprises

View All Earnings Estimates

PureTech Health Environmental, Social, and Governance (ESG) Scores

PureTech Stock Institutional Investors

Note, although PureTech Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PureTech Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 404.1 M.

PureTech Profitablity

The company has Profit Margin (PM) of 7.93 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (25.9) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $25.9.

Management Efficiency

PureTech Health PLC has return on total asset (ROA) of (0.1295) % which means that it has lost $0.1295 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0944 %, meaning that it created $0.0944 on every $100 dollars invested by stockholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, PureTech Health's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, PureTech Health's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.08, whereas Total Assets are forecasted to decline to about 554 M.

Technical Drivers

As of the 5th of January, PureTech Health holds the Variance of 7.1, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,126). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PureTech Health, as well as the relationship between them.

PureTech Health PLC Price Movement Analysis

PureTech Health Outstanding Bonds

PureTech Health Predictive Daily Indicators

PureTech Health Corporate Filings

PureTech Health Forecast Models

PureTech Health's time-series forecasting models are one of many PureTech Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PureTech Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

PureTech Health Bond Ratings

PureTech Health PLC financial ratings play a critical role in determining how much PureTech Health have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for PureTech Health's borrowing costs.

PureTech Health PLC Debt to Cash Allocation

PureTech Health PLC currently holds 22.36 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. PureTech Health PLC has a current ratio of 2.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about PureTech Health's use of debt, we should always consider it together with its cash and equity.

PureTech Health Total Assets Over Time

PureTech Health Assets Financed by Debt

The debt-to-assets ratio shows the degree to which PureTech Health uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

PureTech Health Debt Ratio

6.47

It looks as if most of the PureTech Health's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PureTech Health's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PureTech Health, which in turn will lower the firm's financial flexibility.

PureTech Health Corporate Bonds Issued

PureTech Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how PureTech Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PureTech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PureTech Health. By using and applying PureTech Stock analysis, traders can create a robust methodology for identifying PureTech entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PureTech analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PureTech analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

PureTech Health PLC stock analysis indicators help investors evaluate how PureTech Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PureTech Health shares will generate the highest return on investment. By understating and applying PureTech Health stock analysis, traders can identify PureTech Health position entry and exit signals to maximize returns.

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.